We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

244 hedge funds and large institutions have $2.35B invested in Emergent Biosolutions in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 90 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

60% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 20

6% more capital invested

Capital invested by funds: $2.22B → $2.35B (+$135M)

5% more funds holding

Funds holding: 233 → 244 (+11)

1% less repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 90

2.1% less ownership

Funds ownership: 89.26% → 87.16% (-2.1%)

87% less call options, than puts

Call options by funds: $371K | Put options by funds: $2.75M

Holders
244
Holders Change
+11
Holders Change %
+4.72%
% of All Funds
5.35%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
32
Increased
89
Reduced
90
Closed
20
Calls
$371K
Puts
$2.75M
Net Calls
-$2.38M
Net Calls Change
-$2.39M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$17.4M
2
SAM
Silvercrest Asset Management
New York
+$15.2M
3
Marshall Wace
Marshall Wace
United Kingdom
+$10.2M
4
Neuberger Berman Group
Neuberger Berman Group
New York
+$10M
5
TCM
Tygh Capital Management
Oregon
+$9.44M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$33.3M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$25.1M
3
Renaissance Technologies
Renaissance Technologies
New York
-$17.1M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.8M
5
Aberdeen Group
Aberdeen Group
United Kingdom
-$9.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
FMII
226
Farmers & Merchants Investments Inc
Nebraska
$6K – – –
ASN
227
Advisory Services Network
Georgia
$5K – – –
FBT
228
First Bank & Trust
South Dakota
$5K – – –
Northwestern Mutual Wealth Management
229
Northwestern Mutual Wealth Management
Wisconsin
$5K – – –
SPIA
230
Steward Partners Investment Advisory
New York
$5K – – –
GAM
231
Gemmer Asset Management
California
$4K – – –
SWM
232
Selective Wealth Management
Virginia
$4K +$3.82K +82 New
Kayne Anderson Rudnick Investment Management
233
Kayne Anderson Rudnick Investment Management
California
$3K – – –
PFBT
234
Parkside Financial Bank & Trust
Missouri
$3K +$512 +11 +22%
IA
235
IFP Advisors
Florida
$3K +$2.42K +52 New
BHWM
236
Bay Harbor Wealth Management
Maryland
$2K – – –
HAM
237
Highstreet Asset Management
Ontario, Canada
$2K – – –
S
238
SignatureFD
Georgia
$2K – – –
TFO
239
Tarbox Family Office
California
$2K – – –
TWA
240
TCI Wealth Advisors
Arizona
$2K – – –
GI
241
Gradient Investments
Minnesota
$2K +$1.35K +29 New
HGWM
242
Harvest Group Wealth Management
Massachusetts
$1K -$1.54K -33 -56%
GT
243
Glenmede Trust
Pennsylvania
$386 +$2.61K +56 +0.8%
Acadian Asset Management
244
Acadian Asset Management
Massachusetts
– -$25.1M -520,302 Closed
MCM
245
Matarin Capital Management
New York
– -$6.93M -143,509 Closed
MCM
246
McKinley Capital Management
Alaska
– -$4.09M -84,640 Closed
Canada Life
247
Canada Life
Manitoba, Canada
– -$2.92M -60,369 Closed
SCM
248
Sio Capital Management
New York
– -$2.34M -48,400 Closed
SSA
249
Schonfeld Strategic Advisors
New York
– -$1.31M -27,200 Closed
KC
250
Kepos Capital
New York
– -$935K -19,363 Closed
7 8 9
10
11

EBS Hedge Fund Activity: Q3 2019 in Review

244 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2019, worth a combined $2.35B — up 6.1% from $2.22B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new EBS positions and 20 closed out — a net gain of 12 holders — while 89 added to existing stakes and 90 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $17.4M. The largest seller was State Street, cutting an estimated $33.3M.

  • 244 institutional investors held Emergent Biosolutions (EBS) as of Q3 2019, up from 233 in Q2 2019.
  • Funds reported $2.35B of Emergent Biosolutions stock for Q3 2019, up 6.1% quarter-over-quarter.
  • 32 funds opened new Emergent Biosolutions positions in Q3 2019 and 20 closed out, a net change of +12 holders.
  • The largest Emergent Biosolutions buyer in Q3 2019 was Millennium Management, an estimated $17.4M added.
  • The largest Emergent Biosolutions seller in Q3 2019 was State Street, an estimated $33.3M sold.

Based on aggregated 13F filings for Q3 2019.